Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-PD-L1 ANTIGEN BINDING PROTEIN, AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/063352
Kind Code:
A1
Abstract:
Provided is an anti-PD-L1 antigen binding protein, capable of binding to primate-derived PD-L1 with a KD value of 1×10-8M or less. The antigen binding protein can block the binding of PD-1 and CD80 to PD-L1, stimulate the secretion of cytokines in immune cells, and can inhibit tumor growth and/or tumor cell proliferation. Also provided is a fusion protein, comprising human TGFBRII or a fragment thereof and the antigen binding protein. Also provided is an application of the antigen binding protein and/or the fusion protein in the prevention and treatment of tumors or cancers.

Inventors:
HE YUN (CN)
REN SHUWEN (CN)
LIU BIN (CN)
GAN XIN (CN)
LI DONGHAI (CN)
CHEN FEI (CN)
WANG LING (CN)
LI JIN (CN)
RONG YIPING (CN)
Application Number:
PCT/CN2020/118811
Publication Date:
April 08, 2021
Filing Date:
September 29, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HARBOUR BIOMED SHANGHAI CO LTD (CN)
International Classes:
A61K38/17; C07K16/28; A61K39/395; A61P35/00; C07K19/00; C12N15/13; C12P21/06
Domestic Patent References:
WO2016162368A12016-10-13
WO2018205985A12018-11-15
Foreign References:
CN106939047A2017-07-11
CN106939047A2017-07-11
CN104961829A2015-10-07
CN104961829A2015-10-07
CN106103488A2016-11-09
US20190169621A12019-06-06
US20190218296A12019-07-18
Other References:
VALECHA G. K.: "Anti–PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy", EXPERT REVIEW OF ANTICANCER THERAPY, vol. 17, no. 1, 23 November 2016 (2016-11-23), pages 47 - 59, XP055798118
LUAN Y. ET AL.: "A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity", INTERNATIONAL IMMUNOPHARMACOLOGY, vol. 31, 12 January 2016 (2016-01-12), XP029412996, DOI: 10.1016/j.intimp.2015.12.039
KABAT ET AL.: "Protein Sequences of Immunology", 1991, NATIONAL INSTITUTES OF HEALTH
AL-LAZIKANI ET AL., J MOL BIOL, vol. 273, 1997, pages 927 - 48
ISHIDA ET AL., EMBO J, vol. 11, 1992, pages 3887 - 3395
OKAZAKI ET AL.: "Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice", SCIENCE, vol. 291, 2001, pages 319 - 22
FREEMAN ET AL.: "Engagement of PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation", J. EXP.MED., vol. 192, 2000, pages 1027 - 1034, XP002942545, DOI: 10.1084/jem.192.7.1027
CARTER ET AL.: "PD-1: PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2", EUR. J. IMMUNOL., vol. 32, 2002, pages 634 - 643, XP002980901, DOI: 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
"NCBI", Database accession no. NP -001271065
"Uniprot", Database accession no. P37173
"Epitope Mapping Protocols in Methods in Molecular Biology", vol. 66, 1996
CUNNINGHAMWELLS, SCIENCE, vol. 244, 1985, pages 1081
W. R. PEARSOND. J. LIPMAN: "Improved tools for biological sequence comparison", PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 2444 - 2448
D. J. LIPMANW. R. PEARSON: "Rapid and sensitive protein similarity searches", SCIENCE, vol. 227, 1989, pages 1435 - 1441
S. ALTSCHULW. GISHW. MILLERE. W. MYERSD. LIPMAN: "A basic local alignment search tool", J. MOL. BIOL., vol. 215, 1990, pages 403 - 410
SAMBROOK J.FRITSCH, E. F.MANIAIS, T.: "Molecular Cloning: A Laboratory Manual", 1989, COLD SPRING HARBOR LABORATORY PRESS
AUSUBE ET AL.: "Current Protocols in Molecular Biology", 1993, GREENE PUBLISHING AND WILEY-INTERSCIENCE
Attorney, Agent or Firm:
SHANGHAI DIANSHI PARTNERS, P.C. (CN)
Download PDF: